Single dose of DPX-rPA, an enhanced-delivery anthrax vaccine formulation, protects against a lethal Bacillus anthracis spore inhalation challenge

The current study investigated the immunogenicity and protective response of rPA antigen formulated with the DPXTM no-release delivery platform (DPX-rPA). This unique formulation promotes a depot effect that attracts antigen-presenting cells to the vaccination site and elicits an immune response following single-dose delivery.

World reference laboratory for foot-and-mouth disease celebrates 60th Anniversary

Pirbright was designated as the world reference laboratory for foot-and-mouth disease (WRLFMD) by the Food and Agriculture Organization of the United Nations (FAO) in 1958. Over the past 60 years, the WRLFMD has played a leading role in coordinating international networks that improve laboratory diagnostic capacity and undertake global surveillance for FMD.